Richard S. Levy, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 42,378 shares at $296.68 ($12.4M) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $12.4M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $285.28 | 100 | $29K | 0.2% |
| 2 | $287.08 | 400 | $115K | 0.9% |
| 3 | $288.91 | 300 | $87K | 0.7% |
| 4 | $288.91 | 300 | $87K | 0.7% |
| 5 | $290.36 | 1,600 | $465K | 3.7% |
| 6 | $291.66 | 3,325 |
| $970K |
| 7.8% |
| 7 | $291.66 | 3,325 | $970K | 7.8% |
| 8 | $292.68 | 5,227 | $1.5M | 12.3% |
| 9 | $292.68 | 5,227 | $1.5M | 12.3% |
| 10 | $293.54 | 3,548 | $1.0M | 8.4% |
| 11 | $293.54 | 3,548 | $1.0M | 8.4% |
| 12 | $294.68 | 5,164 | $1.5M | 12.2% |
| 13 | $294.68 | 5,164 | $1.5M | 12.2% |
| 14 | $295.45 | 2,325 | $687K | 5.5% |
| 15 | $295.45 | 2,325 | $687K | 5.5% |
| 16 | $296.68 | 500 | $148K | 1.2% |
| Total | $293.29 avg | 42,378 | $12.4M | 100% |
| Filing → |
| TARA | BUY | 2025-05-19 | $64K | — | Filing → |
| MDGL | SELL | 2024-11-08 | $1.8M | — | Filing → |
| MDGL | SELL | 2024-11-05 | $2.7M | — | Filing → |